BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14608544)

  • 1. Cytogenetic evidence for the origin of neoplastic cells in CD5-positive marginal zone B-cell lymphoma.
    Batstone P; Forsyth L; Goodlad JR
    Hum Pathol; 2003 Oct; 34(10):1065-7. PubMed ID: 14608544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features.
    Dierlamm J; Pittaluga S; Wlodarska I; Stul M; Thomas J; Boogaerts M; Michaux L; Driessen A; Mecucci C; Cassiman JJ; De Wolf-Peeters C; Van den Berghe H
    Blood; 1996 Jan; 87(1):299-307. PubMed ID: 8547655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse.
    Ferry JA; Yang WI; Zukerberg LR; Wotherspoon AC; Arnold A; Harris NL
    Am J Clin Pathol; 1996 Jan; 105(1):31-7. PubMed ID: 8561085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas.
    Brynes RK; Almaguer PD; Leathery KE; McCourty A; Arber DA; Medeiros LJ; Nathwani BN
    Mod Pathol; 1996 Oct; 9(10):995-1000. PubMed ID: 8902837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N; Durkin L; Bodo J; Hsi ED
    Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases.
    Jaso J; Chen L; Li S; Lin P; Chen W; Miranda RN; Konoplev S; Medeiros LJ; Yin CC
    Hum Pathol; 2012 Sep; 43(9):1436-43. PubMed ID: 22406370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
    Magro CM; Yang A; Fraga G
    Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite Follicular Lymphoma and CD5-Positive Nodal Marginal Zone Lymphoma.
    Miyaoka M; Kikuchi T; Carreras J; Yara Kikuti Y; Omachi K; Kojima M; Ando K; Nakamura N
    J Clin Exp Hematop; 2016; 56(1):55-8. PubMed ID: 27334859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour.
    Wenzel C; Dieckmann K; Fiebiger W; Mannhalter C; Chott A; Raderer M
    Leuk Lymphoma; 2001 Aug; 42(4):823-9. PubMed ID: 11697516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5-Negative Primary Mantle Cell Lymphoma Presenting with a Bilateral Conjunctival Mass: A Potential Diagnostic Pitfall.
    Zanelli M; Lugli A; Palicelli A; Sanguedolce F; Zizzo M; Cresta C; Biancafarina S; Martino G; Crescenzi B; Pancetti S; Broggi G; Caltabiano R; Cimino L; Mecucci C; Ascani S
    Curr Oncol; 2023 Jan; 30(1):824-831. PubMed ID: 36661711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases.
    Kojima M; Sato E; Oshimi K; Murase T; Koike T; Tsunoda S; Matsumoto T; Marutsuka K; Ogiya D; Moriuchi M; Tokunaka M; Yara Kikuti Y; Kikuchi T; Nakamura N; Ando K
    J Clin Exp Hematop; 2010; 50(2):107-12. PubMed ID: 21123968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
    Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
    Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodal marginal zone B cell lymphoma with prominent follicular colonization with deletion of chromosome 13.
    Tabata R; Tabata C; Nagai T; Yasumizu R; Kojima M
    Pathol Res Pract; 2012 Nov; 208(11):679-82. PubMed ID: 22963839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5+ low-grade marginal zone B-cell lymphomas with localized presentation.
    Ballesteros E; Osborne BM; Matsushima AY
    Am J Surg Pathol; 1998 Feb; 22(2):201-7. PubMed ID: 9500221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features of CD5-positive nodal marginal zone lymphoma.
    Jaso JM; Yin CC; Wang SA; Miranda RN; Jabcuga CE; Chen L; Medeiros LJ
    Am J Clin Pathol; 2013 Nov; 140(5):693-700. PubMed ID: 24124149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
    Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma with the features of mucosa-associated lymphoid tissue (MALT) lymphoma in an HTLV-I-seropositive patient.
    Shibata K; Shimamoto Y; Nakano S; Miyahara M; Nakano H; Yamaguchi M
    Ann Hematol; 1995 Jan; 70(1):47-51. PubMed ID: 7530056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.